[Pain analysis is vital in rheumatic diseases. The pain is often the patient's worst problem].

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Transliterated Title:
      Smärtanalys vital vid reumatiska sjukdomar. Smärtan oftast patientens största bekymmer.
    • Source:
      Publisher: Sveriges Lakarforbund Country of Publication: Sweden NLM ID: 0027707 Publication Model: Print Cited Medium: Print ISSN: 0023-7205 (Print) Linking ISSN: 00237205 NLM ISO Abbreviation: Lakartidningen Subsets: MEDLINE
    • Publication Information:
      Original Publication: Stockholm : Sveriges Lakarforbund
    • Subject Terms:
    • Abstract:
      The article consists of a synthesis of a rheumatic pain symposium held at the annual meeting of the Swedish Medical Association in 1996. Various aspects of pain in rheumatic diseases were discussed, such as physiological, neurohumoral and neurogenic mechanisms, sensory stimulation treatment, differentiation of mechanical and inflammatory pain, quality enhancement by improved cooperation between primary and tertiary care facilities, pharmacological treatment with (centrally and peripherally acting) opioids, selective cyclo-oxygenase inhibitors, and NMDA (N-methyl-D-aspartate) receptor antagonists. The aim of the symposium, with its focus on the manifest pain problem, was to improve our knowledge and skill in the understanding and treatment of this large patient category. For patients with rheumatic disorders exacerbated by pain problems, as for other patients, a pain diagnosis is of fundamental importance. This can be achieved by analysis of the social, psychological, physiological and medical factors contributing to the cause and degree of pain and to pain behaviour, and of the extent to which the pain may be nociceptive (i.e., inflammatory, mechanical, or ischaemic in origin), neurogenic or idiopathic. Pain analysis should be followed by individualised treatment focused on the patient's most crucial problems, thus enhancing the prospect of optimal treatment outcome.
    • Number of References:
      20
    • Accession Number:
      0 (Analgesics)
    • Publication Date:
      Date Created: 19980429 Date Completed: 19980421 Latest Revision: 20111117
    • Publication Date:
      20240829
    • Accession Number:
      9542822